The European Commission (EC) has granted conditional marketing authorization for Madrigal Pharmaceuticals' Rezdiffra (resmetirom) for the treatment of adults with noncirrhotic metabolic ...

The US Food and Drug Administration (FDA) has extended Regenxbio’s review timeline of the Biologics License Application (BLA) ...

The Alzheimer’s disease (AD) market across the eight major markets (8MM: USA, France, Germany, Italy, Spain, UK, Japan, and ...

Today’s announcement (August 20) on draft guidelines from the UK’s National Institute for Health and Care Excellence (NICE) ...

Germany’s Institute for Quality and Efficiency in Health Care concluded that Columvi (glofitamab) monotherapy shows no added ...

The US regulator has issued draft guidance urging drug developers to prioritize overall survival as the primary endpoint in ...

In a significant shift for the US pharmaceutical landscape, President Donald Trump has formally announced in May 2025, a push ...

Washington, USA-based immunotherapy specialist Adaptive Biotechnologies (Nasdaq: ADPT) said Monday that its strategic ...

Shanghai Henlius Biotech today revealed it has entered into a strategic collaboration with fellow Chinese drug developer ...

Shares of San Diego, USA-based Viking Therapeutics tumbled 43% to $23.50 by mid-morning after the company released mid-stage ...

Heidelberg, Germany-based research institute BioMed X announced a new collaboration with Denmark’s Novo Nordisk, which aims ...

Privately-held US biotech Skyhawk Therapeutics has announced a strategic research collaboration with Germany’s Merck KGaA ...